Literature DB >> 8430113

Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue.

D Lazard1, X Sastre, M G Frid, M A Glukhova, J P Thiery, V E Koteliansky.   

Abstract

The expression of several differentiation markers in normal human mammary gland myoepithelium and in certain stromal fibroblasts ("myofibroblasts") associated with breast carcinomas was studied by immunofluorescence microscopy of frozen sections. Several antibodies to smooth muscle-specific proteins (smooth muscle alpha-actin, smooth muscle myosin heavy chains, calponin, alpha 1-integrin, and high molecular weight caldesmon) and to epithelial-specific proteins (cytokeratins, E-cadherin, and desmoplakin) were used to show that myoepithelial cells concomitantly express epithelial and smooth muscle markers whereas adjacent luminal cells express only epithelial markers. The same antibodies were used to establish that stromal myofibroblasts exhibit smooth muscle phenotypic properties characterized by the expression of all the smooth muscle markers examined except for high molecular weight caldesmon. In addition, both myoepithelium and myofibroblasts show a significant degree of heterogeneity in smooth muscle protein expression. Thus, myoepithelial cells and stromal myofibroblasts are epithelial and mesenchymal cells, respectively, which coordinately express a set of smooth muscle markers while maintaining their specific original features. The dual nature of myoepithelial cells and the phenotypic transition of fibroblasts to myofibroblasts are examples of the plasticity of the differentiated cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430113      PMCID: PMC45798          DOI: 10.1073/pnas.90.3.999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin.

Authors:  M G Frid; B V Shekhonin; V E Koteliansky; M A Glukhova
Journal:  Dev Biol       Date:  1992-10       Impact factor: 3.582

2.  Plasticity of the differentiated state.

Authors:  H M Blau; G K Pavlath; E C Hardeman; C P Chiu; L Silberstein; S G Webster; S C Miller; C Webster
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells.

Authors:  M A Glukhova; A E Kabakov; O I Ornatsky; T D Vasilevskaya; V E Koteliansky; V N Smirnov
Journal:  FEBS Lett       Date:  1987-06-29       Impact factor: 4.124

4.  Immunohistochemical localization of smooth muscle myosin in normal human tissues.

Authors:  J A Longtine; G S Pinkus; K Fujiwara; J M Corson
Journal:  J Histochem Cytochem       Date:  1985-03       Impact factor: 2.479

5.  Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.

Authors:  M E Hemler; F Sanchez-Madrid; T J Flotte; A M Krensky; S J Burakoff; A K Bhan; T A Springer; J L Strominger
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.

Authors:  A P Sappino; O Skalli; B Jackson; W Schürch; G Gabbiani
Journal:  Int J Cancer       Date:  1988-05-15       Impact factor: 7.396

7.  Characterization of myosin heavy chains in cultured aorta smooth muscle cells. A comparative study.

Authors:  S Kawamoto; R S Adelstein
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

8.  Intermediate-sized filaments of the prekeratin type in myoepithelial cells.

Authors:  W W Franke; E Schmid; C Freudenstein; B Appelhans; M Osborn; K Weber; T W Keenan
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

9.  A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes.

Authors:  A M Gown; A M Vogel; D Gordon; P L Lu
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

10.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  82 in total

1.  Differential expression of high molecular weight caldesmon in colorectal pericryptal fibroblasts and tumour stroma.

Authors:  H Nakayama; E Miyazaki; H Enzan
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

2.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

Authors:  C Sundberg; J A Nagy; L F Brown; D Feng; I A Eckelhoefer; E J Manseau; A M Dvorak; H F Dvorak
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.

Authors:  T Ueda; N Araki; M Mano; A Myoui; S Joyama; S Ishiguro; H Yamamura; K Takahashi; I Kudawara; H Yoshikawa
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

4.  High molecular weight caldesmon positive stromal cells in the capsule of thyroid follicular tumours and tumour-like lesions.

Authors:  H Nakayama; H Enzan; E Miyazaki; T Moriki; H Kiyoku; M Toi; N Kuroda; M Hiroi
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

5.  High molecular weight caldesmon positive stromal cells in the capsule of hepatocellular carcinomas.

Authors:  H Nakayama; H Enzan; M Yamamoto; E Miyazaki; W Yasui
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

6.  Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.

Authors:  Stephanie C Lebret; Donald F Newgreen; Mark C Waltham; John T Price; Erik W Thompson; M Leigh Ackland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Nov-Dec       Impact factor: 2.416

7.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.

Authors:  Giulia Grisendi; Rita Bussolari; Elena Veronesi; Serena Piccinno; Jorge S Burns; Giorgio De Santis; Pietro Loschi; Marco Pignatti; Fabrizio Di Benedetto; Roberto Ballarin; Carmela Di Gregorio; Valentina Guarneri; Lino Piccinini; Edwin M Horwitz; Paolo Paolucci; Pierfranco Conte; Massimo Dominici
Journal:  Am J Cancer Res       Date:  2011-05-28       Impact factor: 6.166

8.  Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Authors:  Sung-Hee Chang; Catherine H Liu; Rebecca Conway; David K Han; Kasem Nithipatikom; Ovidiu C Trifan; Timothy F Lane; Timothy Hla
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

9.  Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.

Authors:  Nathalie Dourdin; Babette Schade; Robert Lesurf; Michael Hallett; Robert J Munn; Robert D Cardiff; William J Muller
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 10.  Understanding and treating triple-negative breast cancer.

Authors:  Carey Anders; Lisa A Carey
Journal:  Oncology (Williston Park)       Date:  2008-10       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.